Rheumatic Heart Disease Recruiting Phase 3 Trials for Rivaroxaban (DB06228)

Also known as: Rheumatic Heart Diseases / Rheumatic carditis / RHD / Rheumatic heart disease, unspecified / Unspecified rheumatic heart disease / Rheumatic heart disease NOS

IndicationStatusPhase
DBCOND0000392 (Rheumatic Heart Disease)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03926156RIvoraxaban in Mitral StenosisTreatment
NCT02832544INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-InferiorityPrevention